Friday, October 23, 2026

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix, French bonds and housing.

CRWV $30BTSLA $1.5T

Steve Eisman Oct 23 28 clicks

Oct 23 CRWV $30B

Our Views on CoreWeave

WHAT ARE WE DOING? “Contrarians At The Gate” 12 clicks

Oct 23 BE $56B

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Cestrian Capital Research 8 clicks

From X

@TidefallCapital Oct 23

Trevor Scott on X

$APP Past 5 year insider transactions: Sales: $15,825,097,564 Buys: $0 https://t.co/mIgIStK0yO

@kevin__mak Oct 23 3 clicks

Kevin Mak on X

$ABVX Couple things I noted today. 1) The ABVX fans love to talk about how bad this specific stock is. But looking at a group of late-stage, pre-commercial biotech peers since August 20th, the weakness looks a lot less ABVX-specific. ABVX is down ~26%, versus a peer median of ~27%. Different stories and catalysts, but ABVX is right in the middle of the group. 2) The latest Markit securities-lending update shows a sharp drop in reported shares on loan, from ~2.6m to ~460k. My read is that this is consistent with the possible “large short” I previously flagged having covered. The drop shows up in the October 21 data, immediately after the October 20 +5.8% rally, which has since largely fizzled out. Disclosure: Creek Drive and its affiliated funds holds a long position in ABVX. Views expressed are current opinions for information only, subject to change and are not investment advice or a recommendation to buy or sell any security. Investing involves the risk of loss and past performance is not indicative of future performance. See the disclosures link in my bio for more important information.

@BarbarianCap Oct 23 2 clicks

Barbarian Capital on X

LKQ Ousts CEO, Warns of Third-Quarter Shortfall $LKQ https://t.co/e4GW6GlTN0

@BarbarianCap Oct 23

Barbarian Capital on X

Moderna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype $MRNA https://t.co/rpuprTlXsY

@BarbarianCap Oct 23

Barbarian Capital on X

"a price that is more than double that of competitor VantageScore 4.0" FICO Holds $10 Pricing for Mortgage Lenders Amid New Competition $FICO https://t.co/kyjJl8RsJj

@RagingVentures Oct 23

Raging Capital Ventures on X

$ASTS market cap today: $16 billion https://t.co/TVBwjYUiu6

@gnoble79 Oct 23

George Noble on X

Thanks my friend. $CRWV is also a zero. https://t.co/U7PIMg8X3k

@absreturnchaser Oct 23 4 clicks

absreturnchaser on X

Is Western Union $WU shopping a takeover offer they have received? @jfineman @laurenthomas @mroliverbarnes @DNair5 @bharringtonw11

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $314B

Librarian Capital's Research Library Oct 23 3 clicks

Amazon’s Trainium Takes a Strike at the Training King

Amazon’s Trainium3 adds native PyTorch training support, targeting CUDA-trained researchers with standard APIs, eager mode and…

AMZN $2.8T

SemiAnalysis Oct 23 7 clicks

Alphabet: Gemini 4 Argon Is Coming For ChatGPT's Lunch

Alphabet's Gemini 4 Argon aims to undercut rival AI models using proprietary TPUs, while Android, Siri and Google Cloud distribution…

GOOGL $3.9T

Dustin Quasney Oct 23 3 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B

Net Interest Oct 23 11 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $108B

MBI Deep Dives Oct 23 3 clicks

Big Tech Will Spend More on AI This Year Than Walmart Sells

Alphabet, Amazon, Meta and Microsoft plan nearly $800 billion of AI infrastructure spending, testing whether incremental returns can stay…

GOOGL $3.9TMSFT $3.9T

Ezra's Notes Oct 23 5 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $11B

TSOH Investment Research Oct 23 4 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $260B

Cestrian Capital Research Oct 23 6 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

TEM $11BMRNA $98B

Edmund Ingham Oct 23 4 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B

Best Anchor Stocks Oct 23 14 clicks

[P] HUBS: CiC Returns Management

HubSpot’s executive severance plan governs payouts following a change in control.

HUBS $13B

Nongaap Investing May 6

Warren Buffett’s Final Brushstrokes

Berkshire Hathaway will replace Warren Buffett as CEO with Greg Abel at year-end, while Buffett remains chairman and Abel assumes capital…

BRK.A $1.2T

The Rational Walk May 5

Berkshire Hathaway’s Diamond Anniversary

Berkshire Hathaway marks 60 years under Warren Buffett as board retirement rules and Buffett’s comments prepare shareholders for Greg…

BRK.A $1.2T

The Rational Walk Apr 30

Brookfield Corp. - Get a Buck for Fifty Cents

Brookfield Corp. trades at 13.2x 2025 distributable earnings and $45.97 against management’s $91.76 sum-of-the-parts Plan Value, discounted…

BN $84B

310 Value’s Newsletter Apr 10 3 clicks

FrontView REIT (NYSE: FVR)

FrontView REIT’s 35% selloff after tenant credit problems and a lock-up expiry leaves its net-lease portfolio at a 9.5% cap rate and 10.5x…

FCPT $2.7B

Real Assets, Real Value Apr 7

ILMN: Activism! Part Deux

Illumina appointed activist Keith Meister to its board as an SEC investigation into the Grail acquisition raises questions over 122.5…

ILMN $40BGRAL $6.3B

Nongaap Investing Apr 2

[P] ILMN: Activist In, Chairman Out

Illumina adds activist Keith Meister to its board as Chairman Stephan Macmillan resigns.

ILMN $40B

Nongaap Investing Mar 26

Berkshire Hathaway’s 2025 Proxy Statement

Berkshire Hathaway’s 2025 proxy introduces an age-80 director limit, forcing Ronald Olson’s retirement while exempting Warren Buffett and…

BRK.A $1.2T

The Rational Walk Mar 15

CNK Buyback, Special Situation Review, and Some Thoughts on Theaters

Cinemark’s $200 million buyback anchors a review of theater cost structures, MCS and a completed Fairfax preferred-share special situation.

CNK $4.6B

Base Hit Investing Mar 7

An Unnoticed Filing Shows This Company is Preparing for a Sale

Phinia revised executive contracts to raise CEO severance to $5.25 million and guarantee full equity vesting in a sale after its spin-off…

PHIN $2.1B

Easy Value Mar 6

Friday, October 23, 2026

Trevor Scott on X

Kevin Mak on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Raging Capital Ventures on X

George Noble on X

absreturnchaser on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 62 of 254

X accounts we follow

Investor letters we follow

Sectors